Expansion to Interdisciplinary HIV Prevention in Women
HIV, AIDS, Fetal Alcohol Syndrome
About this trial
This is an interventional prevention trial for HIV focused on measuring Prevention, HIV, AIDS, Fetal Alcohol Syndrome (FAS), Alcohol Related Neurodevelopmental Disorder (ARND)
Eligibility Criteria
Inclusion Criteria:
- A parent study participants who completed HIV risk survey and
- Reported two or more partners in the last 12 months and no or inconsistent condom use in the last 3 months and no HIV testing in the last 12 months
- Or reported any sexually-transmitted disease and no HIV testing in the last 12 months
Exclusion Criteria:
- A parent study participants who declined to be contacted for participating in future research studies
Sites / Locations
- University of Oklahoma
- St. Petersburg State University
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Opt-in testing
Opt-out testing
Participants will be scheduled for a two-hour appointment to complete the written consent procedure, enroll in the study, and participate in the study activities, testing and a focus group. Opt-in: Common barriers to HIV screening testing will be removed as much as possible (i.e., providing rapid testing, results shortly available, testing on-site, confidentiality). "There is voluntary HIV testing available to all study participants if you wish to do it. "
Participants will be scheduled for a two-hour appointment to complete the written consent procedure, enroll in the study, and participate in the study activities, testing and a focus group. Opt-out multicomponent testing. Participants will be informed that a bundled routine health test is available on a voluntary basis to study participants, and the participant may elect to decline all or part of the testing.